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DObjective: Patients with Stanford type B dissection treated medically during the acute phase have a risk of sur-
gery and aortic rupture during the chronic phase.We investigated the predictors for late aortic events by focusing
on the false lumen status with computed tomography.
Methods: A total of 160 patients were enrolled in the study, with a mean follow-up interval of 44.6  25.4
months. Patients were divided into 3 groups according to the false lumen status at the time of onset: group
T, thrombosed in 49 patients (30.6%); group U, thrombosed with ulcer-like projections in 52 patients
(32.5%); and group P, patent in 59 patients (36.9%).
Results: The mean aortic enlargement rate of groups U and P was greater than that of group T (0.40 0.91 mm/
month in group U, 0.44 0.49 mm/month in group P, and0.016 0.23 mm/month in group T). The event-free
rate in groups U and P was lower than in group T: 5-year event-free rates of 67.4%  8.2% in group U and
57.7% 10.9% in group P versus 95.0% 4.9% in group T (group T vs group U: P¼ .0011, group U vs group
P: P¼ .96, group P vs group T: P¼ .0004). Cox regression analysis revealed that the false lumen status (patent or
ulcer-like projections) (P ¼ .029), maximum aortic diameter at onset (P<.0001), and patient age (P ¼ .0069)
were predictors of the late aortic events.
Conclusions: In type B aortic dissection, a thrombosed false lumen with ulcer-like projections and a patent false
lumen had an influence on late aortic dilation and late aortic events. (J Thorac Cardiovasc Surg 2011;142:e25-31)Conservative medical management is usually the first
choice of treatment for Stanford type B acute aortic dissec-
tion (AAD) without complications, such as rupture, malper-
fusion, and persistent pain. However, during the follow-up
period some patients die of aortic rupture or show aortic di-
lation requiring intervention. At the time of onset, it is dif-
ficult to identify which patients will have these events in the
chronic phase. In terms of late events, patients with type B
AAD and a patent false lumen had poorer outcomes than
those with a thrombosed false lumen (intramural hematoma
[IMH]). There are 2 types of IMH: with or without ulcer-
like projection (ULP). The role of ULPs as a prognostic fac-
tor in AAD has been discussed in the literature,1-3 although
there are several conclusions and few descriptions with
regard to the prognosis of ULPs. There is also controversy
over the appropriate management for this condition. We
compared the clinical features and prognosis of type B
AAD among 3 groups divided according to false lumen
status (patent, thrombosed, or ULPs in thrombosed falsee Division of Cardiovascular Surgery, Hyogo Brain and Heart Center at
ji, Hyogo, Japan.
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The Journal of Thoracic and Calumen) and identified predictors of late aortic events
on the basis of patients’ parameters at the time of onset.
We hypothesized that the prediction of risk factors from
morphologic features and close follow-up with surgical
interventions might improve the long-term outcome of
uncomplicated type B AAD.MATERIALS AND METHODS
Study Population
Between September 2000 and May 2009, we examined data from all
191 consecutive patients with type B AAD who visited the emergency de-
partment of the Hyogo Brain and Heart Center at Himeji at the time of
onset. Type B AAD was defined as any nontraumatic dissection not
involving the ascending aorta and presenting within 14 days of symptom
onset. Of the 191 patients, 169 were followed up as cases treated success-
fully with antihypertensive therapy during the acute phase. The reasons
for the exceptions during the acute phase included 4 cases of aortic rupture
and 18 cases of emergency surgical interventions (2 cases of aortic rup-
ture, 6 cases of persistent pain or enlargement of aortic diameter, and
10 cases of ischemia of limbs or abdominal organ). During the follow-
up period, 5 patients were excluded because of surgery for other true
aneurysms of the aorta. In those 5 patients, true aneurysms were diagnosed
at the onset of AAD and were located separately proximal to the dissected
aorta. Another 4 patients whose follow-up intervals were less than
6 months were excluded from this study. A total of 160 patients with
type B AAD were enrolled in this study as outpatients. The mean
follow-up time was 44.6 months (range, 6.3–99.9 months).The mean
age of the patients at onset was 66.1 years (range, 18–89 years), and 37
patients (23.1%) were female (Table 1). We obtained informed consent
from all patients. The study protocol was reviewed and approved by the
institutional database and office records, and the study complied with
the Declaration of Helsinki.rdiovascular Surgery c Volume 142, Number 2 e25
Abbreviations and Acronyms
AAD ¼ acute aortic dissection
CT ¼ computed tomography
IMH ¼ intramural hematoma
PAU ¼ penetrating atherosclerotic ulcer
TEVAR ¼ thoracic endovascular aortic repair
ULP ¼ ulcer-like projection
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DDiagnosis and Predictive Variables
The diagnosis of type B dissection was confirmed with the use of en-
hanced computed tomography (CT) immediately after the emergency ad-
mission. Data were reviewed by an experienced radiologist in a blind
manner. By using the results from this radiologic examination at emer-
gency admission, we obtained data regarding the status in the false lumen
(patent, thrombosed, or thrombosed false lumen complicated by ULPs) and
the maximum diameter of the dissected aorta. In each patient, we measured
the maximum aortic diameter in 2 segments: segment 1, from an aortic bi-
furcation of the left subclavian artery to the descending aorta that is equal to
the level of the tracheal bifurcation; and segment 2, below segment 1. The
maximum aortic diameter is defined as the largest short-axis diameter of
the outer contour of aorta in the axial direction. This was measured at least
twice, in the initial CT images performed at the time of onset and in the
most recent follow-up CT images. In patients who underwent surgery dur-
ing the chronic phase, the diameter was measured on CT images obtained
immediately before surgery. The mean aortic enlargement rate (diameter)
was obtained by dividing the difference in the maximum aortic diameter
between the initial and the most recent CT images (millimeters) by the in-
terval (months) in the same segment. CT examinations were performed
with a variety of scanners. CTexaminations were performedwith a 16-slice
helical CT scanner (Aquilion 16; ToshibaMedical Systems Co, Ltd, Tokyo,
Japan) from September 2000 to September 2004, andwith a 64-slice helical
CT scanner (Aquilion 64, Toshiba Medical Systems Co, Ltd) from October
2004 to , all obtaining axial images with contiguous 7.0-mm–thick sections
from the top of the aortic arch to the iliac bifurcation. Contrast-enhanced
CTwas performed with a bolus injection of 100 mL iopamidol (Iopamiron
300; Schering, Tokyo, Japan) at a rate of 3.5 mL/sec via an automated in-
jector. All CT images were available on the picture archiving and commu-
nications system. These data on the acute phase and the basicTABLE 1. Basic characteristics among groups
Characteristics
Group T
N ¼ 49
(30.6%)
Age, y (mean  SD, range) 69.5  8.9, 54-89
Sex (female,%) 36.7
Peripheral artery disease (%) 4.1
Hypertension (%) 34.7
Ischemic heart disease (%) 6.1
CT findings at onset
Aortic dilation in segment 1, N (%) 44 (89.8)
Extent of dissection, N (%)
DeBakey IIIa 21 (42.9)
DeBakey IIIb 28 (57.1)
Maximum aortic diameter at onset (mm) 36.5  5.1
SD, Standard deviation; CT, computed tomography; NS, not significant. *Group T vs group
group U: P¼ .028, group U vs group P: NS, group P vs group T:P¼ .020. zGroup T vs grou
NS, group U vs group P: P<.0001, group P vs group T: P<.0001. kGroup T vs group U
e26 The Journal of Thoracic and Cardiovascular Surgcharacteristics (age, sex, concomitant hypertension, ischemic heart disease,
and peripheral artery diseases, including cerebrovascular and the extremi-
ties) are shown in Table 1 as predictive variables for aortic enlargement dur-
ing the chronic phase. All 160 patients were divided into 3 groups
according to clinical features associated with the status of the false lumen.
We defined a thrombosed false lumen as a false lumen that was not en-
hanced at the early or delayed phase. Forty-nine patients (30.6%) had
a thrombosed false lumen, labeled as group T. ULPs were defined as any
focal, blood-filled pouch projecting into the thrombosed false lumen.
Fifty-two patients (32.5%) fulfilled this definition, labeled as group U. A
patent false lumen is a false lumen that was enhanced at an early or delayed
phase. There were 59 patients (36.9%) who met this status of the false lu-
men, labeled as group P. Nineteen patients (32.2%) in group P had partial
thrombosis of the false lumen in which both flow and thrombus were pres-
ent. Group P also included 4 patients with connective tissue disorders.
We investigated the predictors for late aortic events defined as an end
point of progressive aortic pathology including rupture and expansion or
malperfusion with need for open surgery or thoracic endovascular aortic re-
pair (TEVAR).
Treatment and Follow-up
Almost all patients with type BAAD received calcium-channel blockers
by continuous intravenous infusion to control blood pressure immediately
after admission to the Hyogo Brain and Heart Center at Himeji. Some pa-
tients required additional nitric acid agents. When oral administration was
possible, oral formulations of these agents were administered. In principle,
patients without severe heart failure or obstructive pulmonary disease re-
ceived b-blockers concurrently with additional calcium-channel blockers
and angiotensinII receptor blocker as appropriate. While maintaining ade-
quate urine production, blood pressure was controlled with a target systolic
level of 120 mm Hg. After discharge, patients continued to receive oral
medications at a local clinic or our hospital. In addition, surgery was per-
formed in patients with complications such as rupture or an increased aortic
diameter. Follow-up was obtained by office visits and telephone interviews
with the patients or their families.
Statistical Analysis
All continuous variables are expressed as the mean  standard devia-
tion. Comparison of the clinical and radiologic characteristics was per-
formed by the chi-square analysis for categoric variables and by Student
t test for continuous variables. Cox regression analysis was used to identify
the predominant predictors for late aortic events throughout the entireGroup U
N ¼52
(32.5%)
Group P
N ¼ 59
(36.9%) P value
70.5  7.9, 53-85 60.0  15.4, 18-87 *
17.3 16.9 y
13.4 8.5 NS
38.4 30.5 NS
5.8 5.1 NS
35 (67.4) 47 (79.7) z
x
25 (48.1) 3 (5.1)
27 (51.9) 56 (94.9)
41.5  6.0 39.0  6.3 k
U: NS, group U vs group P: P<.0001, group P vs group T: P ¼ .0002. yGroup T vs
p U: P¼ .0062, group U vs group P: NS, group P vs group T: NS. xGroup T vs group U:
: P<.0001, group U vs group P: P ¼ .037, group P vs group T: P ¼ .028.
ery c August 2011
Miyahara et al Acquired Cardiovascular Diseasefollow-up period. The values of actuarial freedom from late aortic events
and survival were computed by using the Kaplan–Meier technique and
compared using the log-rank test. These data analyses were performed
with StatView 5.0 forWindows (SAS Institute Inc, Cary, NC). Receiver op-
erating characteristic curve was processed by SPSS 13.0 for Windows
(SPSS, Inc, Chicago, Ill).A
C
DRESULTS
Differences in basic characteristics among the 3 groups
are shown in Table 1. There were more female patients in
group T compared with the other groups (group T vs group
U: P¼ .028, group U vs group P: P¼ .96, group P vs group
T: P ¼ .020). A significant difference was not seen among
groups in terms of hypertension, concomitant ischemic
heart disease, and peripheral artery disease. Patients in
group Pwere significantly younger than patients in the other
2 groups, with a mean age of 60.0  15.4 years, versus
69.5  8.9 years in group T and 70.5  7.9 years in group
U (group T vs group U: P ¼ .54, group U vs group P:
P<.0001, group P vs group T: P ¼ .0002). The maximum
aortic diameters at the onset were the largest in group U,
with a mean diameter of 41.5  6.0 mm, versus 39.0 
6.3 mm in group P and 36.5  5.1 mm in group T (group
T vs group U: P<.0001, group U vs group P: P ¼ .037,
group P vs group T: P ¼ .028). The largest segment of the
aorta in each group is shown in Table 1. Patients in group
T tended to have proximal aortic dilatation in the descend-
ing aorta (segment 1). Patients who had the largest aortic di-
ameter in segment 2 showed enlargement in the descending
or thoracoabdominal aorta, not in the lower abdominal
aorta. During the follow-up period, some patients have
had a shift to other false lumen status. The number of pa-
tients who crossed over into other groups is shown in
Figure 1. The mean aortic enlargement rate (diameter) is
shown in Table 2. Patients whose maximum aortic diameter
decreased were mostly in group T. Almost all patients in
group P showed aortic dilation during a follow-up period.
In group U, some patients showed a reduction in the maxi-
mum aortic diameter, whereas others showed a rapid
enlargement of the maximum aortic diameter in a shortFIGURE 1. The number of cross-overs between groups.
The Journal of Thoracic and Caperiod. The mean aortic enlargement rate in groups U and
P was greater than that in group T, with statistical signifi-
cance (0.40  0.91 mm/month in group U, 0.44  0.49
mm/month in group P, and 0.016  0.23 mm/month in
group T) (group T vs group U: P¼ .0024, group U vs group
P: P ¼ .78, group P vs group T: P<.0001).
During the follow-up period, 26 patients (16.3%) under-
went elective surgery because of aortic diameter enlarge-
ment. Five patients (3.1%) had aortic rupture; however,
only 1 patient survived with surgery. One patient with
a 55-mm thoracic aneurysm refused operation because of
her pulmonary comorbidities. The operative procedures
performed in these 27 patients and other aortic events are
shown in Table 3. Figure 2, A shows the Kaplan–Meier
curve indicating freedom from aortic events. The mean
follow-up for the 160 patients examined in this analysis
was 33.5  20.5 months (range, 2.0–88.0 months). The
event-free rate at 1, 3, and 5 years was 92.2%  2.2%,
84.2%  3.2%, and 71.0%  5.5%, respectively.
Figure 2, B shows the Kaplan–Meier event-free curves strat-
ified by the groups. The event-free rate was highest in group
T, with 1-, 3-, and 5-year event-free rates of 100.0% 
0.0%, 100.0%  0.0%, and 95.0%  4.9%, respectively,
versus 90.3% 4.1%, 76.0% 6.4%, and 67.4% 8.2%
in group U and 87.7% 4.4%, 80.2% 5.8%, and 57.7%
 10.9% in group P, respectively. A separate log-rank test
showed that the event-free rate in groups U and P was sig-
nificantly lower than in group T (group T vs group U:
P ¼ .0011, group U vs group P: P ¼ .96, group P vs group
T: P ¼ .0004). A subgroup analysis was performed, which
excluded 4 patients with connective tissue disorders in
group P, that showed no difference in the event-free rate
compared with the entire study group analysis (T vs U:
log-rank P ¼ .0007, U vs P: log-rank P ¼ .8989, P vs T:
log-rank P ¼ .0013). The cumulative survival of the entire
study group at 1, 3, and 5 years was 98.7% 0.9%, 92.2%
 2.4%, and 87.2%  3.4%, respectively (Figure 2, C),
and there was no significant difference among the groups
(mean follow-up: 44.6  25.4 months; range, 6.3–99.9
months) (Figure 2, D). Survival at 5 years in groups T, U,
and P was 93.8%  4.3%, 78.7%  2.1%, and 91.9% 
4.0%, respectively (group T vs group U: P ¼ .67, group
U vs group P: P ¼ .12, group P vs group T: P ¼ .44).
Among the 160 patients during the chronic phase, 142
survived and 18 died, of whom 4 died of aortic rupture
(2 in group U and 2 in group P). The other 14 deaths were
not caused by aortic events: subarachnoid hemorrhage in
3 patients, respiratory failure in 3 patients, malignancy in
2 patients, pneumonia in 2 patients, trauma in 1 patient,
heart failure in 1 patient, renal failure in 1 patient, and sud-
den death in 1 patient in group T. There was no hospital
death among the patients who underwent surgical aortic re-
placement or endovascular repair in the chronic phase. The
survival between the event group (N ¼ 32; including deathrdiovascular Surgery c Volume 142, Number 2 e27
TABLE 2. Growth length of maximum aortic diameter
Group T
N ¼ 49
Group U
N ¼ 52
Group P
N ¼ 59 P value
Diameter (mm/mo) 0.016  0.23 0.40  0.91 0.44  0.49 *
Cases of growing, N (%) 19 (38.8) 42 (80.7) 57 (96.6) y
*Group T vs group U: P¼ .0024, group U vs group P: P¼ .78, group P vs group T: P<.0001. yGroup T vs group U: P<.0001, group U vs group P: P¼ .0073, group P vs group T:
P<.0001.
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Dof aortic rupture) and non-event group (N¼ 128) showed no
significant difference (Figure 2, E).
The 10 variables listed in Table 4 correlated with aortic
events throughout the entire follow-up period. With the
use of univariate analysis, age (61.3  16.6 years in event
group, vs 67.6  10.8 years in non-event group,
P ¼ .010), maximum aortic diameter at onset (43.9 
7.34 mm in event group, vs 37.8  5.11 mm in non-event
group, P<.0001), and false lumen status (patent or throm-
bosed with ULPs) (group P or U) (P ¼ .0002) were signif-
icantly correlated with late aortic events. To determine the
statistical significance of the predictor variables, Cox re-
gression analysis was performed and revealed that age
(P ¼ .0069), maximum diameter at onset (P<.0001), and
false lumen status (patent or ULPs) (P ¼ .029) were signif-
icant predictive factors of late aortic events (Table 4). The
maximum aortic diameter at onset showed greater statistical
significance. Sensitivity and specificity of the maximum
aortic diameter to the late aortic events were 61.3%
and 73.4% with a maximum aortic diameter cutoff of
40.5 mm (P<.001; 95% CI, 0.642–0.844).
DISCUSSION
Patients with acute type B aortic dissection without com-
plications such as rupture or organ ischemia should be
treated medically in the acute phase.4,5 In the chronic
phase, some patients who survived through the acute
phase die of aortic rupture. To prevent aortic rupture in
the chronic phase, it is important to carefully observe all
patients and make a decision about surgical interventions
for patients with an enlarged aortic diameter. Many
studies have indicated predictors of a late aortic event.6-11TABLE 3. Details of the late aortic events
Late aortic events N (%)
Elective surgery
Descending aortic replacement 9 (28.1)
Thoracoabdominal aortic replacement 8 (25.0)
Total arch replacement 5 (15.6)
TEVAR 3 (9.4)
Abdominal aortic replacement 1 (3.1)
Emergency surgery
Descending aortic replacement 1 (3.1)
Rupture 4 (12.5)
Other 1 (3.1)
TEVAR, Thoracic endovascular aortic repair.
e28 The Journal of Thoracic and Cardiovascular SurgThe present study shows that a late aortic event in type B
AAD is correlated with 3 independent predictors: false
lumen status (patent or thrombosed with ULPs), patient
age, and maximum aortic diameter at onset. Previous
studies have suggested a higher risk of late aortic events
in patients with a patent false lumen than in those with
a thrombosed false lumen.8-10,12 We demonstrated that
patients with a thrombosed false lumen and ULPs have an
equally poor prognosis as those with a patent false lumen,
with a relatively large cohort and a long follow-up period.
In the present series, patients with a patent false lumen
had a greater tendency to have an enlarged aortic diameter
compared with those with a thrombosed false lumen. Ex-
pansion of aortic diameter during the chronic phase of
type B AAD is primarily caused by enlargement of the pat-
ent false lumen, and patients with this sign have a significant
tendency to undergo surgical interventions or die of aortic
rupture.10,11,13 Williams and colleagues14 showed that in-
creases in the size of the patent, elastin-poor, pressurized
false lumen caused an enlargement of overall aortic diame-
ter in an in vitro model.14
For several decades, it has been said that there is an ath-
erosclerotic lesion with ulceration that penetrates the inter-
nal elastic lamina, often resulting in hematoma within the
media of the aortic wall, and that has been recognized as
an atypical aortic dissection.15 These penetrating athero-
sclerotic ulcers (PAUs) are mostly visualized radiologically
as ULPs. Our study indicated that patients with a throm-
bosed false lumen and complicating ULPs were at risk for
late aortic events, as well as those with a patent false lumen,
and the mean aortic enlargement rate of this entity was
closer to that of patients with a patent false lumen. It has
been thought that ULPs frequently tended to enlarge and
progress to aneurysms.2,16-18 Tisnado and associates19 re-
ported that ULPs in an aortogram may progress into estab-
lishing a false lumen, and this indicates a possible rupture.
Many ULPs progressed to saccular aneurysms or recanal-
ized into a false lumen in this study (Figure 3, A, B). Ganaha
and colleagues1 clarified the differences of clinical features
and prognosis between IMH with PAU and IMH without
PAU by showing their early outcome. Jang and colleagues2
demonstrated that the incidence of complications, such as
aneurysm formations and dissections, in IMH with PAU
was higher than in IMH without PAU. Our results virtually
followed these 2 studies. On the other hand, Quint and col-
leagues3 showed that most ULPs remain unchanged overery c August 2011
FIGURE 2. A, Freedom from aortic events in entire study group. B, Freedom from aortic events in each group; P values were calculated by the log-rank
test. C, Cumulative survival of entire study group. D, Cumulative survival of each group; P values were calculated by the log-rank test. E, Cumulative sur-
vival of event group (N = 32) and non-event group (N ¼ 128); P values were calculated by the log-rank test.
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Dtime and that one third of ULP lesions progress with mild
aortic enlargement; the mean increase in aortic diameter
was 15% (range, 5%–45%) in follow-up CT performed
5 to 50 months (mean, 19.8 months) after discharge. The
definition of ULP still remains unclear; it is considered to
represent the site of an intimal tear, the site of occlusion,
or the detachment of the orifice of aortic branches orThe Journal of Thoracic and CaPAUs.2,20 In our cohort, we regarded any blood-filled pouch
projecting into the thrombosed false lumen as a ULP, and
patients with ULPs were more likely to have a poor progno-
sis because of late aortic events.
In total, 4 dissection-related deaths occurred throughout
the entire study period, and all of them had an aortic rupture
at other hospitals or were transferred to our hospital inrdiovascular Surgery c Volume 142, Number 2 e29
TABLE 4. Statistical analysis of predictors for late aortic events
Cox proportional hazard analysis
Variables Univariate P P value Hazard ratio 95% CI
Age .0103 .0069 0.965 0.941–0.990
Female .5117
Aortic dilation in distal arch .1221
Max diameter at onset <.0001 <.0001 1.151 1.091–1.215
Patent false lumen or ULPs .0002 .029 9.578 1.260–72.804
Ischemic heart disease .1468
Peripheral artery diseases .4013
Hypertension .2119
DeBakey IIIa .4402
Connective tissue disorder .1287
CI, Confidence interval; ULP, ulcer-like projection.
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Dshock. In balancing the risk of aortic rupture, it is important
to closely observe patients in risk groups and assess whether
they would be a candidate for surgical interventions. Esti-
mating the substantial risk associated with surgery is also
fundamental. Otherwise, the cumulative survival among
our 3 groups showed no significant differences. This means
that our surgical results were acceptable, and the surgical in-
terventions achieved a successful outcome in a long follow-
up period. On the other hand, only 3 patients were managed
with endovascular repair in the late chronic phase (2 in
group P and 1 in group T, who crossed over to group U).
Nienaber and colleagues21 did not demonstrate a survival
benefit of prophylactic TEVAR in the INSTEAD trial; how-FIGURE 3. A, ULP in distal arch progressed to a saccular aneurysm 27months
6 months later.
e30 The Journal of Thoracic and Cardiovascular Surgever, they showed evidence of aortic remodeling, expansion
of the thoracic true lumen, and thrombosis of the false lu-
men 2 years after intervention. The morphologic feature
of their study group was patent false lumen: completely pat-
ent in 63.9% and partial thrombosis in 36.1%. Nienaber
and colleagues applied prophylactic interventions in the
early chronic phase.21 Although our approach for type B
aortic dissection was different from that of INSTEAD, en-
dovascular repair in the early chronic phase has benefit
for a risk group, especially patients with pulmonary comor-
bidities or the elderly. A prophylactic TEVAR for a throm-
bosed false lumen with ULPs has substantial merit, as well
as for a patent false lumen.later. B, ULP (black arrow) in descending aorta recanalized into false lumen
ery c August 2011
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DAnother finding of the present investigation is that aortic
diameter at onset was a strong independent risk factor of
late aortic events. Many previous studies reached an agree-
ment about this result with a cutoff diameter of 40 to
45 mm.6-8,11,12 We derived the cutoff diameter of
40.5 mm from a receiver operating characteristic curve.
The maximum aortic diameter was largest in group U,
which was statistically significant.
Study Limitations
Therewas a relatively small number of patients with a fol-
low-up period more than 5 years in each group. In addition,
a variety of CT scanners were used according to the study
period.
CONCLUSIONS
We evaluated the prognosis in patients with type B AAD
who received medical treatment in their initial hospitaliza-
tion. The incidence of late aortic events was higher in pa-
tients with a thrombosed false lumen complicated by
ULPs and in patients with a patent false lumen. When pa-
tients have these 2 types of false lumen, especially with
a maximum aortic diameter greater than 40 mm at onset,
careful and regular follow-up CTexaminations are required,
and surgical interventions including TEVAR should be con-
sidered in case of aortic enlargement.
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